STAAR Surgical adds three board members in cooperation deal
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St futures rise on tech buying, Middle East peace hopes
- Oracle results beat estimates, but shares fall on plans for $40 billion raise
- Oil falls as traders digest escalation in US-Iran strikes
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Alibaba falls on China AI capex report; Citi says selloff is premature
- Crude Inventory Fell 7.2 Million Barrels Last Week, Says EIA
- Wall Street indexes fall more than 1%, hit by tech, Iran war worries
- UBS sees generational semiconductor boom, highlights stock winners
STAAR Surgical and Broadwood Partners Enter Into Cooperation Agreement
January 15, 2026 8:30 AM ESTNeal Bradsher and Richard LeBuhn of Broadwood and Christopher Wang of Yunqi Capital have Joined STAAR Board
STAAR Chair Elizabeth Yeu and CEO Stephen Farrell have Stepped Down from the Board
Farrell will Remain CEO until January 31, 2026
LAKE FOREST, Calif.--(BUSINESS WIRE)-- STAAR Surgical Company (STAAR or the Company) (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL) for vision correction, and Broadwood Partners, L.P. and its affiliates... More
